Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
BBH: Mature Biotech Exposure, But Limited Growth Ahead
04:26pm, Wednesday, 21'st Jan 2026
BBH: Mature Biotech Exposure, But Limited Growth Ahead
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Tuesday, 06'th Jan 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20,
VanEck Announces Year-End Distributions for VanEck Equity ETFs
08:24pm, Friday, 19'th Dec 2025
NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2025 annual distributions per share for its VanEck equity exchange-traded funds.
Boston Research & Management Inc. Lowers Stock Holdings in VanEck Biotech ETF $BBH
03:55am, Sunday, 23'rd Nov 2025
Boston Research and Management Inc. lessened its holdings in shares of VanEck Biotech ETF (NASDAQ: BBH) by 4.4% during the second quarter, according to the company in its most recent filing with the S
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Tuesday, 04'th Nov 2025
The VanEck Biotech ETF (BBH) was launched on December 20, 2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity marke
AMG and Brown Brothers Harriman Announce Strategic Collaboration
06:59am, Wednesday, 01'st Oct 2025
BBH and AMG to Partner in Developing New Products for the U.S. Wealth Marketplace, Leveraging BBH's Industry-Leading Structured and Alternative Credit Expertise and AMG's Proven Product Development an
Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz
03:32pm, Wednesday, 03'rd Sep 2025
Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the differences in the biotech ETFs and much more.
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH
08:03am, Monday, 01'st Sep 2025
Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading innovators wit
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 01'st Sep 2025
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20,
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 30'th Jun 2025
Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
BBH: Fear Of Price Controls Is Not The Problem
09:00am, Wednesday, 14'th May 2025
The executive order aims to reduce drug prices by allowing direct sales to consumers and cutting out PBMs but faces significant challenges. The main risk for biotech is FDA approval delays due to skep
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Tuesday, 29'th Apr 2025
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Tuesday, 25'th Feb 2025
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Tuesday, 24'th Dec 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
08:56pm, Friday, 20'th Dec 2024
NEW YORK--(BUSINESS WIRE)--VanEck has announced the 2024 annual distributions per share for its VanEck equity exchange-traded funds (ETFs).
